Pneumonia News and Research

Latest Pneumonia News and Research

Vaccine deal signed - 47 developing countries to receive low priced vaccines by 2015

Pharmaceutical giants have signed a historical 10-year deal on Tuesday pledging the supply of 60 million doses a year of pneumococcal vaccines at cut-prices to developing nations.

24 Mar 2010

HIV-infected patients face increase risk of CA-MRSA infections, says study

HIV-infected patients are at a markedly increased risk for community acquired Methicillin-resistant Staphylococcus aureus (CA-MRSA) infections according to a new study by researchers at John H. Stroger, Jr. Hospital of Cook County and Rush University Medical Center.

24 Mar 2010

Royal Philips Electronics introduces Lifeline with AutoAlert solution

Royal Philips Electronics today introduced Lifeline with AutoAlert, an enhanced medical alert service. This integrated solution offers an added layer of protection by combining the industry-leading Philips Lifeline medical alert service with automatic fall detection capabilities.

From Philips Healthcare 23 Mar 2010

First reported Australian swine flu case of 2010 – gearing up with protective measures

Swine flu a form of influenza, became a major health scare assuming pandemic proportions starting in Mexico early last year. There were 37,000 confirmed cases in Australia with 5,000 hospitalizations, 700 admissions in intensive care units and 191 deaths.

23 Mar 2010

Chest x-rays may help identify high-risk H1N1 patients

A new study published in the April issue of Radiology suggests that chest x-rays may play an important role in the diagnosis and treatment of H1N1 influenza by predicting which patients are likely to become sicker.

23 Mar 2010

New understanding of cell in immune system may guide creation of effective flu vaccines: Study

A new understanding of a certain cell in the immune system may help guide scientists in creating better flu vaccines, report researchers from the Program in Cellular and Molecular Medicine and the Immune Disease Institute at Children's Hospital Boston.

23 Mar 2010

Influenza pandemic policies: WHO denies being improperly influenced by pharmaceutical industry

Providing independent advice to Member States is a very important function of the World Health Organization (WHO). We take this work seriously and guard against the influence of any improper interests. The WHO influenza pandemic policies and response have not been improperly influenced by the pharmaceutical industry.

20 Mar 2010

SHEA, APIC awarded first Partnership in Prevention Award to National Guard Health Affairs in Saudi Arabia

During the Fifth Decennial International Conference on Healthcare-Associated Infections, the Society for Healthcare Epidemiology of America and the Association for Professionals in Infection Control and Epidemiology awarded their first Partnership in Prevention Award to the National Guard Health Affairs in Saudi Arabia.

20 Mar 2010

Implementation of evidenced-based practices reduces all healthcare-associated MRSA infections

Scientists at The Virginia Commonwealth University Medical Center found that an emphasis on compliance with non-pathogen specific infection control practices such as hand hygiene, efforts to reduce device-related infections and chlorhexidine bathing (a daily bath with the same antibacterial agent used by surgeons to "scrub in" before an operation), is successful in reducing rates of healthcare-associated methicillin-resistant Staphylococcus aureus.

19 Mar 2010

Overall mortality rates at Bay Medical Center in Panama City drop 1.3 points

Overall mortality rates from the end of 2007 to the beginning of 2010 at Bay Medical Center in Panama City, Florida have dropped from 3.4 to 2.1. A 1.3-point drop represents a huge reduction for any hospital and translates into lives saved.

19 Mar 2010

Genocea Biosciences acquires global license for novel Streptococcus pneumoniae antigens from Children’s Hospital Boston

Genocea Biosciences, a vaccine discovery and development company, today announced an exclusive worldwide license for developed countries to a portfolio of Streptococcus pneumoniae antigens from Children’s Hospital Boston. PATH and Genocea retain certain co-exclusive rights to the antigens for use in developing countries under their collaboration agreements with Children's Hospital Boston.

18 Mar 2010

Nature News examines GAVI Alliance's budget gap

Nature News examines GAVI Alliance's multi-billion-dollar budget shortfall ahead of a donors meeting in The Hague on March 25-26.

18 Mar 2010

Prevenar 13: Immunogenic and well tolerated in young children previously vaccinated with Prevenar

According to results from a Phase III safety and immunogenicity study presented today, Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine, [13-valent, adsorbed]) was shown to be immunogenic and generally well tolerated in healthy young children who had received at least three prior doses of Prevenar (Pneumococcal Saccharide Conjugated Vaccine, Adsorbed). These data were presented today at the 7th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD) in Tel Aviv, Israel.

17 Mar 2010

IDSA calls for global commitment to develop 10 new antibiotics by 2020

As the deaths and suffering caused by antibiotic-resistant bacterial infections continue to rise around the world, the Infectious Diseases Society of America (IDSA) is urging a global commitment to develop 10 new antibiotics by 2020, known as the 10 x '20 initiative, to address this public health crisis and safeguard patients' health.

17 Mar 2010

Today's Opinions and Editorials

After a year of national debate, a handful of House Democrats who oppose abortion may be the ones to decide whether health care reform goes forward or not. ... We are puzzled and dismayed that these legislators are willing to waste that opportunity because they say the onerous anti-abortion provisions in the Senate's bill are still not onerous enough (3/14).

15 Mar 2010

More focus on reaching MDGs needed, development officials say

During a conference in London Thursday, development officials urged world leaders to "accelerate efforts to meet the Millennium Development Goals (MDGs) by 2015 and [said] rich countries must make good on promises to boost aid to poorer nations," Reuters AlertNet reports.

15 Mar 2010

GAVI Alliance reaches agreement with drugmakers on reduced-price pneumococcal vaccines

Several drugmakers have reached an agreement "to supply up to 200 million doses a year of cut-price pneumococcal vaccines to developing nations," according to GAVI Alliance, Reuters reports.

15 Mar 2010

TaiGen Biotechnology's nemonoxacin Phase II study in DFI meets primary endpoints

TaiGen Biotechnology Co., Ltd. announced today the Phase II trial of nemonoxacin (TG-873870) in Diabetic Foot Infection (DFI) with once-a-day dosing met the primary endpoints and showed promising clinical efficacy and good tolerability.

12 Mar 2010

Post-marketing safety studies for LABAs: AstraZeneca confident of SYMBICORT in treatment of asthma

On March 10-11, 2010, the Joint Advisory Committees of the U.S. Food and Drug Administration (FDA) -- including the Pulmonary-Allergy Drugs and the Drug Safety and Risk Management Advisory Committees -- discussed the design of post-marketing safety studies for long-acting beta-agonist (LABA)-containing products in the U.S., including SYMBICORT® (budesonide/formoterol fumarate dihydrate).

12 Mar 2010

Children with chronic illness more likely to develop H1N1 influenza: Study

As critical care professionals develop a better understanding of the progression of H1N1, they are becoming better prepared to treat children with severe cases, according to a new study that will be published in the March issue of Pediatric Critical Care Medicine (PCCM).

12 Mar 2010

Pneumonia News and Research

Latest Pneumonia News and Research

Vaccine deal signed - 47 developing countries to receive low priced vaccines by 2015

HIV-infected patients face increase risk of CA-MRSA infections, says study

Royal Philips Electronics introduces Lifeline with AutoAlert solution

First reported Australian swine flu case of 2010 – gearing up with protective measures

Chest x-rays may help identify high-risk H1N1 patients

New understanding of cell in immune system may guide creation of effective flu vaccines: Study

Influenza pandemic policies: WHO denies being improperly influenced by pharmaceutical industry

SHEA, APIC awarded first Partnership in Prevention Award to National Guard Health Affairs in Saudi Arabia

Implementation of evidenced-based practices reduces all healthcare-associated MRSA infections

Overall mortality rates at Bay Medical Center in Panama City drop 1.3 points

Genocea Biosciences acquires global license for novel Streptococcus pneumoniae antigens from Children’s Hospital Boston

Nature News examines GAVI Alliance's budget gap

Prevenar 13: Immunogenic and well tolerated in young children previously vaccinated with Prevenar

IDSA calls for global commitment to develop 10 new antibiotics by 2020

Today's Opinions and Editorials

More focus on reaching MDGs needed, development officials say

GAVI Alliance reaches agreement with drugmakers on reduced-price pneumococcal vaccines

TaiGen Biotechnology's nemonoxacin Phase II study in DFI meets primary endpoints

Post-marketing safety studies for LABAs: AstraZeneca confident of SYMBICORT in treatment of asthma

Children with chronic illness more likely to develop H1N1 influenza: Study

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Pneumonia News and Research

Latest Pneumonia News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in